Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review
Top Cited Papers
Open Access
- 3 April 2007
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (7) , 1127-1134
- https://doi.org/10.1038/sj.bjc.6603649
Abstract
We combined information published worldwide on the seroprevalence of hepatitis B surface antigen (HbsAg) and antibodies against hepatitis C virus (anti-HCV) in 27 881 hepatocellular carcinomas (HCCs) from 90 studies. A predominance of HBsAg was found in HCCs from most Asian, African and Latin American countries, but anti-HCV predominated in Japan, Pakistan, Mongolia and Egypt. Anti-HCV was found more often than HBsAg in Europe and the United States.Keywords
This publication has 13 references indexed in Scilit:
- Cancer incidence in people with hepatitis B or C infection: A large community-based linkage studyJournal of Hepatology, 2006
- Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in TaiwanInternational Journal of Cancer, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Serological pattern “anti-HBc alone”: Characterization of 552 individuals and clinical significanceWorld Journal of Gastroenterology, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Pakistan: a cirrhotic state?The Lancet, 2004
- Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.Cancer, 2004
- Cambodia protects 75% of children against parasites.2004
- Clinical guidelines on the management of hepatitis CGut, 2001
- Global surveillance and control of hepatitis CJournal of Viral Hepatitis, 1999